astragaloside a has been researched along with Insulin Sensitivity in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dongming, W; Dudu, WU; Kangrui, Y; Xiaomei, YE; Xiaowei, X; Zhi, C; Zhiqiang, YU | 1 |
| Cao, SS; Feng, L; Han, CJ; Liu, JP; Shi, LL; Shi, Y; Wang, B; Wang, X; Zhang, RH; Zhang, YH | 1 |
| Chen, D; Guo, X; Xu, S; Ye, R; Yin, T; Zhang, Y | 1 |
| Tang, B; Tang, WJ; Wang, LL; Zhou, X | 1 |
| Dong, X; Han, Y; Li, W; Li, Y; Su, Y; Zhang, J; Zhang, Y; Zhu, Y | 1 |
| Chen, L; Gu, B; Huang, S; Zheng, J; Zhu, R | 1 |
| Chen, M; Jiang, B; Jin, H; Qian, L; Shang, W; Yang, Y; Zhou, L | 1 |
| Ou-Yang, Y; Sun, YH; Xiao, SZ; Xu, ME; Zheng, XX | 1 |
8 other study(ies) available for astragaloside a and Insulin Sensitivity
| Article | Year |
|---|---|
Astragaloside IV ameliorates insulin induced insulin resistance in HepG2 cells through reactive oxygen species mediated c-Jun N-terminal kinase pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Rats; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2023 |
Astragaloside IV-mediated inhibition of oxidative stress by upregulation of ghrelin in type 2 diabetes-induced cognitive impairment.
Topics: AMP-Activated Protein Kinases; Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Ghrelin; Insulin Resistance; Oxidative Stress; Rats; Superoxide Dismutase-1; Up-Regulation | 2023 |
Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes
Topics: Adipocytes; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin Resistance; Interleukin-6; MicroRNAs; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Tumor Necrosis Factor-alpha | 2023 |
Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells.
Topics: Cell Survival; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Insulin Resistance; Oleic Acid; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Saponins; Triglycerides; Triterpenes | 2021 |
Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR‑mediated autophagy.
Topics: AMP-Activated Protein Kinases; Animals; Astragalus propinquus; Autophagy; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Homeostasis; Insulin Resistance; Liver; Male; Oxidative Stress; Quality of Life; Rats; Rats, Sprague-Dawley; Saponins; Streptozocin; TOR Serine-Threonine Kinases; Triterpenes | 2021 |
Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway.
Topics: Animals; Biological Transport; Cell Line; Chemokine CCL2; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; I-kappa B Kinase; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Mice; Models, Biological; Muscle Fibers, Skeletal; NF-KappaB Inhibitor alpha; Palmitic Acid; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction; Toll-Like Receptor 4; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |
Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFalpha in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Analysis of Variance; Animals; Carrier Proteins; Fatty Acid Synthases; Fatty Acids, Nonesterified; Gene Expression Regulation; Insulin Resistance; Lipolysis; Medicine, Chinese Traditional; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Perilipin-1; Phosphoproteins; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2008 |
Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.
Topics: Adipocytes; Animals; Apoptosis; Astragalus propinquus; Calcium; Cell Differentiation; Cell Survival; Cells, Cultured; Endothelial Cells; Glucose; Insulin Resistance; Male; Metabolic Syndrome; Plant Roots; Plants, Medicinal; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2006 |